Fundz

Fundz Deep Dive

Everything you need to win Alexander Shaw — in one platform.

Who to reach, what to say, and why now on Alexander Shaw — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Alexander Shaw — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Archimedic Appoints M. Alexander Shaw, Ph D, As Chief Executive Officer and Eric Sugalski As Chief Technology Officer

PRIVATESep 12, 2024•almost 2 years ago

Position

Chief Executive Officer

Company

Archimedic

Alexander Shaw
ChesterBiotechnologyHealth CareMedicalinformation technology & services

Description

Archimedic has appointed M Alexander Shaw, PhD, as its Chief Executive Officer. In this role, Dr Shaw will lead the company in helping companies transform novel technologies into market-ready products. Eric Sugalski, the company's founder, will assume the role of Chief Technology Officer, leveraging his extensive background in engineering, regulatory affairs, and commercial strategy to help clients advance their technologies into market-focused, derisked solutions.

Company Information

Company

Archimedic

Location

835 Lincoln Ave

Chester, Pennsylvania, United States

About

Archimedic is a medical device Design firm with integrated Regulatory and Go-to-Market capabilities to drive the commercial success of its clients. Since 2009, Archimedic has been helping companies develop drug delivery, surgical, diagnostic, and home health medical devices. Helping medtech innovators transform napkin sketch concepts into market-ready medical devices, Archimedic’s work is advancing cancer care, preventing hip fractures, improving outcomes for extremely premature infants, reducing the cost of life-changing drugs, and much more. Archimedic helps companies with product development, quality & regulatory affairs, and commercialization strategy.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Archimedic's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.